While I agree it is not a deadline, rob has come out in 2 CC stating a pilot program would start by July/Aug.
Not sure what the problem in getting pilot program started. In addition, what has happened with the non-existent Calcitriol roll out. Rob said he wanted a 1 year supple in the 1stQ CC. Still not aware of any big roll out.
Hope he can do better with Triferic.
Agree with everything you said. 75% of the patients need Triferic for the iron supplement. The other 25% would use a different solution.
Why lunch both Triferic and Calcitriol together. Calcitriol was approved, what, June/July 14. In 2 CC he said they wanted a year supply in inventory (which makes no sense). Now what is the hold up??
My gut says mid to late Sept. Maybe we will also get some news on the non-existent Calcitriol roll out which was approved last year some time.
That is what MS was concerned with - how fast can RMTI get Triferic to market. As one analysis commented:
"There is no doubt that the non-existent Calcitriol roll out is mind numbing?! I have never seen such a lack of follow through to get an approved ANDA to market, and I have closely followed generic companies for 30 years"
Hopefully Rob can do better with Triferic.
I think long-term we are good, but short term is questionable unless Rob does something magical. It is still possible, but.....
Thumbs up only please - no thumbs down
If u do not need iron replacement, why use Triferic. Even Rob has acknowledged this. They will use
Per RMTI, Triferic is an iron delivering drug.
The Company’s one-of-a-kind iron maintenance drug Triferic received FDA approval on January 24, 2015 and CMS unique product reimbursement code Q9976 on June 1, 2015 in preparation for commercial launch. While the human body needs iron, free iron is toxic and can cause inflammation, infection, oxidative stress, allergic reactions including anaphylaxis, and death. Iron must be bound to a protective shell, called a ligand, for safe transportation within the body. Triferic iron is bound to pyrophosphate, an ideal ligand for iron as it is more tightly bound than any other iron – preventing the release of free iron; it is a natural, physiologic chelator of iron; an antioxidant and an inhibitor of vascular and soft tissue calcification.
98% of all chronic units mix bicarb in a mixer every morning and use the bicarb solution in that mixer over the course of the day, and they have been doing this for 30 years. Rockwell sells the mixers in 25 gal & 50 gal sizes. Triferic would be added to the mixer for those patients who need the iron replacement. For the 25% not requiring iron replacement, their solution would be mixed in a different mixer.
As to pilot testing, that has nothing to do with MS.. All MS is saying it is going to take longer for the pilot programs. If you listed to the CC, Rob stated Pilot Programs would start in July/August.MS 6 days left
I hope this clears up your misss-understanding.
I believe in RMTI but do not understand why Rob cannot get products to market.
I also believe there will have to be a pilot program as in the testing phase, it was not delivered via the mixers.
Half the people commenting does not even realize how Triferic will be delivered.
Everything I post is accurate. It is taken from articles and research reports. You may disagree with the research report. While Morgan Stanly was pushing the envelope, I think they opened everyone eyes getting Triferic to market is going to be a little more time consuming than previous thought.
Per article published by RMTI -Search Rockwell -Triferic
See 2en line
Triferic is a water-soluble iron salt and infused directly to the blood stream, similar to the normal physiologic iron uptake from the ingestion of food. Triferic is formulated for slow, continuous delivery by way of dialysate during every 4-hour dialysis treatment effectively maintaining hemoglobin levels and iron balance without increasing iron stores. Triferic is formulated to replace the 5-7 mg iron that is lost during every dialysis treatment, providing the body with the iron it needs to form red blood cells and transport oxygen, and improves ESA response. Released clinical trial data to-date has shown that small, frequent doses of Triferic, as compared to the current administration of large, infrequent doses of IV iron, is safer and more effective in delivering and maintaining optimal iron balance.
Triferic will added to the mixers that will be delivered to all patients. Those who do not need it will take a different solution.. I spoke to a nurse at one clinic and she said they had 3 mixers, each with different solutions.
MS commented that Triferic had not yet been delivered via the mixer and thus a pilot program is required using Triferic in bulk.
Not sure where you have been, but the objective is to eliminate the need for injecting iron via a needle, which is a cost saving in nurses time, needles.
As to where this came from, below is a quote from Rob:
"Triferic doesn’t require that all patients must receive it. However, all patients will receive it, because it replaces the 5-7mg of iron lost every dialysis treatment that occurs with every patient. It is an iron maintenance therapy. If for some reason a doc wants to bypass a patient then he would simply use a jug of regular liquid bicarb for that patient, but this is highly unlikely to happen."
Rob said he would announce when Pilot Programs started."No pilot testing is occurring at the moment and we made that clear on the earnings call, so this is not news. Pilot testing however is planned to start and continues to be planned".
Once he announces pilot programs start, we will see a pop.